Precipio (PRPO) Stock Forecast, Price & News

0 Wall Street analysts have issued 1-year target prices for Precipio's shares. Their PRPO share price forecasts range from $2.00 to $2.00. On average, they anticipate the company's share price to reach $2.00 in the next twelve months. This suggests that the stock has a possible downside of 64.3%.
View analysts price targets for PRPO or view top-rated stocks among Wall Street analysts.

Precipio's stock was trading at $0.5514 on January 1st, 2023. Since then, PRPO shares have increased by 915.6% and is now trading at $5.60.
View the best growth stocks for 2023 here.

Precipio saw a drop in short interest during the month of August. As of August 31st, there was short interest totaling 198,400 shares, a drop of 33.0% from the August 15th total of 295,900 shares. Based on an average trading volume of 173,200 shares, the days-to-cover ratio is currently 1.1 days.
View Precipio's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our PRPO earnings forecast.

Precipio, Inc. (NASDAQ:PRPO) posted its quarterly earnings data on Friday, August, 11th. The biotechnology company reported ($0.09) EPS for the quarter. The biotechnology company had revenue of $3.53 million for the quarter. Precipio had a negative net margin of 98.50% and a negative trailing twelve-month return on equity of 68.54%.

Precipio's stock reverse split on Friday, September 22nd 2023. The 1-20 reverse split was announced on Friday, September 22nd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, September 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other Precipio investors own include Biocept (BIOC), Heat Biologics (HTBX), Portola Pharmaceuticals (PTLA), iBio (IBIO), Inovio Pharmaceuticals (INO), T2 Biosystems (TTOO), VBI Vaccines (VBIV), Co-Diagnostics (CODX), Inpixon (INPX) and Jaguar Health (JAGX).

Precipio trades on the NASDAQ under the ticker symbol "PRPO."

Precipio's stock is owned by a number of retail and institutional investors. Top institutional investors include Walleye Capital LLC (9.92%). Insiders that own company stock include Ahmed Zaki Sabet, David Seth Cohen, Ilan Danieli and Richard A Sandberg.
View institutional ownership trends.

Shares of PRPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PRPO stock can currently be purchased for approximately $5.60.

Precipio (NASDAQ:PRPO) has a market capitalization of $154.34 million and generates $9.41 million in revenue each year.

Precipio's mailing address is 4 Science Park, New Haven CT, 06511. The official website for the company is www.precipiodx.com. The biotechnology company can be reached via phone at (203) 787-7888, via email at investors@precipiodx.com, or via fax at 402-452-5401.